Skip to content

R&D at other companies

Belden logo
BeldenBDC
$30.09M+5.9%
Cabot Corporation logo
Cabot CorporationCBT
$14M-6.7%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$30M+18.6%
Vontier logo
VontierVNT
$41.4M+3.0%
Archer Aviation logo
Archer AviationACHR
$171.7M+65.6%
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
$27.48M+42.2%

Segments

By segment

See full
Reportable Segment$1.41M+78.2%

Other financials

Income statement

See full
Revenue$45.2M+40.1%
Gross profit$19.2M+39.5%
Operating income-$1.8M+55.0%
Net income$13.8M+125%
EPS (diluted)$0.04+100%

Balance sheet

See full
Cash & equivalents$821.9M+3.0%
Total debt$1.3M-27.8%
Total equity$1.1B+0.7%
Total assets$1.2B+1.6%

Cash flow

See full
Operating cash flow$10.9M+620%
CapEx$1.9M-87.7%
Free cash flow$9.0M+152%

Valuation

See full
Market cap$1.01B+42.3%
Enterprise value$192.08M-352%
P/S6.4×+0.6×

Profitability

See full
Gross margin42.7%+15.1pp
Operating margin-9.5%-4.3pp
Net margin-1.1%-40.8pp
FCF margin16.6%+13.3pp

Returns & leverage

See full
Return on equity-0.2%-4.8pp
Debt / equity0.0×
Current ratio21.9×-5.9×

Where this comes from

Reported directly by Cronos Group in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Cronos Group’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cronos Group's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cronos Group's R&D?
Cronos Group (CRON) reported R&D of $1.41M in Q1 2026.
How has Cronos Group's R&D changed year-over-year?
Cronos Group's R&D increased by 78.2% year-over-year, from $793K to $1.41M.
What is the long-term trend for Cronos Group's R&D?
Over 4 years (2021 to 2025), Cronos Group's R&D has grown at a -32.8% compound annual growth rate (CAGR), from $21.84M to $4.45M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.